rs578042376

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BA1

This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.1252A>T (p.Met418Leu) is a missense variant that has a MAF of 0.005069 (0.5%, 119/23476 alleles) in the East Asian subpopulation of the gnomAD cohort is ≥ 0.0015 (0.15%) (BA1). This missense variant has a REVEL score < 0.50 (0.219) and a SpliceAI score ≤ 0.20 (0.0) (BP4).In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP4 LINK:https://erepo.genome.network/evrepo/ui/classification/CA410147644/MONDO:0011071/008

Frequency

Genomes: 𝑓 0.000035 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0016 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

RUNX1
NM_001754.5 missense

Scores

1
8
10

Clinical Significance

Benign reviewed by expert panel U:1B:1

Conservation

PhyloP100: 3.72

Publications

3 publications found
Variant links:
Genes affected
RUNX1 (HGNC:10471): (RUNX family transcription factor 1) Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
RUNX1 Gene-Disease associations (from GenCC):
  • hereditary thrombocytopenia and hematologic cancer predisposition syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RUNX1NM_001754.5 linkc.1252A>T p.Met418Leu missense_variant Exon 9 of 9 ENST00000675419.1 NP_001745.2 Q01196-8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RUNX1ENST00000675419.1 linkc.1252A>T p.Met418Leu missense_variant Exon 9 of 9 NM_001754.5 ENSP00000501943.1 Q01196-8

Frequencies

GnomAD3 genomes
AF:
0.0000352
AC:
5
AN:
142156
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000254
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000217
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000309
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00157
AC:
1850
AN:
1176830
Hom.:
0
Cov.:
36
AF XY:
0.00153
AC XY:
889
AN XY:
579280
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00374
AC:
100
AN:
26750
American (AMR)
AF:
0.00163
AC:
50
AN:
30618
Ashkenazi Jewish (ASJ)
AF:
0.00526
AC:
100
AN:
19026
East Asian (EAS)
AF:
0.00609
AC:
119
AN:
19534
South Asian (SAS)
AF:
0.000272
AC:
21
AN:
77246
European-Finnish (FIN)
AF:
0.000559
AC:
17
AN:
30436
Middle Eastern (MID)
AF:
0.00191
AC:
9
AN:
4720
European-Non Finnish (NFE)
AF:
0.00137
AC:
1264
AN:
923020
Other (OTH)
AF:
0.00374
AC:
170
AN:
45480
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.249
Heterozygous variant carriers
0
261
521
782
1042
1303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000351
AC:
5
AN:
142312
Hom.:
0
Cov.:
31
AF XY:
0.0000144
AC XY:
1
AN XY:
69222
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000254
AC:
1
AN:
39444
American (AMR)
AF:
0.00
AC:
0
AN:
14530
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3358
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3942
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3872
European-Finnish (FIN)
AF:
0.000217
AC:
2
AN:
9206
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
280
European-Non Finnish (NFE)
AF:
0.0000309
AC:
2
AN:
64800
Other (OTH)
AF:
0.00
AC:
0
AN:
2030
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.255
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:1
-
ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Benign:1
Feb 25, 2025
ClinGen Myeloid Malignancy Variant Curation Expert Panel
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

NM_001754.5(RUNX1):c.1252A>T (p.Met418Leu) is a missense variant that has a MAF of 0.005069 (0.5%, 119/23476 alleles) in the East Asian subpopulation of the gnomAD cohort is ≥ 0.0015 (0.15%) (BA1). This missense variant has a REVEL score < 0.50 (0.219) and a SpliceAI score ≤ 0.20 (0.0) (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Uncertain
0.033
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
22
DANN
Benign
0.97
DEOGEN2
Uncertain
0.51
D;.;.;.
Eigen
Benign
0.097
Eigen_PC
Benign
0.20
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.89
D;D;.;T
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.28
T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Uncertain
2.1
M;.;.;.
PhyloP100
3.7
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-2.1
N;N;N;N
REVEL
Benign
0.22
Sift
Uncertain
0.0050
D;D;D;D
Sift4G
Uncertain
0.019
D;D;D;T
Polyphen
0.032
B;P;P;.
Vest4
0.34
MutPred
0.66
Gain of glycosylation at S390 (P = 0.0427);.;.;.;
MVP
0.54
MPC
0.57
ClinPred
0.78
D
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.59
gMVP
0.57
Mutation Taster
=43/57
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs578042376; hg19: chr21-36164623; API